Production costs, economic viability, and risks associated with compost bedded pack, freestall, and drylot systems in dairy farms.

The adoption of intensive production systems, such as compost bedded pack (CB) and freestall (FS), has increased recently in tropical regions, mainly replacing the drylot system (DL). Thus, our objectives were to compare production costs, economic outcomes, and risk of dairy operations in CB, FS, and DL systems. We collected data from 2 181 Brazilian farms over 120 consecutive months; 960 farms (144 CB, 133 FS, and 683 DL) met our selection criteria. All costs were modeled for two animal production categories: milking cows and non-milking animals. We used a regression model that included linear and quadratic parameters, and we added the production system as a fixed variable for all parameters tested with this model. Consultant, year, herd, and herd × system interaction were included in the model as random variables. Further, we simulated annual technical and economic indexes per farm. In addition, we developed a risk analysis to measure the probability of negative profit of the farms based on a 14-year historical series of milk prices. All production costs were affected by the system. Feed, medicine, sundry, and labor costs per farm per year were greater in DL farms when milk yield (MY) was greater than 3 500 L/day. The variables such as milk yield, assets per liter, asset turnover rate, return on assets, operational profit, profit per cow, and per liter of milk variables were greater in CB and FS with high MY (>3 000 L/day). Nonetheless, DL had the greatest economic indexes with a lower MY (<3 000 L/day), lower operating costs, and greater economic outcomes. The risk analysis indicated that the probability of negative profit (risk) was reduced for CB and FS as MY increased, but DL had the lowest risk with low MY levels. In conclusion, we suggest DL as the most attractive system for farms with MY between 150 and 3 000 L of milk/day as the DL had the lowest risk and the greatest profit in this production scale. Despite similar outcomes for CB and FS in most of the farms, the profit per cow ($/year), assets turnover rate (%), risk (%) and expected profit ($/L) analysis indicated that CB could be recommended for farms with MY greater than 3 200 L of milk/day, whereas based on risk (%) and expected profit ($/L), FS would be the most profitable system in dairies producing more than 8 000 L of milk/day per farm.

Production, economic viability and risks associated with switching dairy cows from drylots to compost bedded pack systems.

The use of compost bedded pack systems (CBS) has increased over the past 5 years in tropical countries, and studies associating production traits with economical outcomes of this system are warranted. Our objectives were to evaluate productive traits, economic outcomes and the risks of losses of dairy farms that switched from a drylot system (DLS) to a CBS and to compare these with similar farms that did not change their system. We collected data from 18 farms over 36 consecutive months (August 2014 to July 2017). All farms started the study as DLS, and six farms switched to CBS in the second year. The other 12 farms kept their DLS during the 36 months of evaluation. Annual technical and economic indexes per farm were collected and calculated. Additionally, a risk analysis was performed based on a 10-year historical series of milk prices. The results were analysed using a regression model including year and herd as categorical variables (fixed), system and herd size as quantitative variables (fixed), and system × herd as a random variable. Furthermore, a non-metric multidimensional scaling plot was used to evaluate producers' profiles in each year. Milk fat, milk total solids, and somatic cell count did not change when farms switched from DLS to CBS, and averaged 3.80%, 12.04%, and 256 500 cells/ml, respectively. However, milk protein (%) decreased in CBS farms. The majority of milk production variables were not affected. Nevertheless, farms that switched to CBS increased milk production per cow by 13.3% compared with DLS farms. Total operation costs (296 076.83 $/year) were not affected by the system, and neither were the costs of concentrates, roughage, labour or medicines. Net margin per litre (0.09 $/l), operating profit (14.95%), assets per litre (398.68 $/l per day) and return on assets (10.27%) did not change when farms switched from DLS to CBS. Net margin ($/l and $/cow) and asset turnover rate increased in CBS farms. Risk analysis indicated that the risk was reduced by 38% in CBS farms. Furthermore, our analysis showed that producers who switched to CBS had similar technical and economic indexes in the first year before switching their system. In conclusion, this study demonstrates that CBS systems might be promising for producers in tropical countries who are looking for a more productive and less risky system. We did not observe improvements in animal health as previously reported in the literature.

Pregnancy success of lactating Holstein cows after a single administration of a sustained-release formulation of recombinant bovine somatotropin.

BACKGROUND: Results regarding the use of bovine somatotropin for enhancing fertility in dairy cattle are variable. Here, the hypothesis was tested that a single injection of a sustained-release preparation of bovine somatotropin (bST) during the preovulatory period would improve pregnancy success of lactating dairy cows at first service. RESULTS: The first experiment was conducted in a temperate region of Mexico. Cows inseminated following natural estrus or timed artificial insemination were given a single injection of bST or a placebo injection at insemination (n = 100 cows per group). There was no significant difference between bST and control groups in the proportion of inseminated cows diagnosed pregnant (29 vs 31% pregnant). The second experiment was performed during heat stress in Florida. Cows were subjected to an ovulation synchronization regimen for first insemination. Cows treated with bST received a single injection at 3 days before insemination. Controls received no additional treatment. As expected, bST did not increase vaginal temperature. Treatment with bST did not significantly increase the proportion of inseminated cows diagnosed pregnant although it was numerically greater for the bST group (24.2% vs 17.8%, 124-132 cows per group). There was a tendency (p = 0.10) for a smaller percent of control cows to have high plasma progesterone concentrations (>/= 1 ng/ml) at Day 7 after insemination than for bST-treated cows (72.6 vs 81.1%). When only cows that were successfully synchronized were considered, the magnitude of the absolute difference in the percentage of inseminated cows that were diagnosed pregnant between bST and control cows was reduced (24.8 vs 22.4% pregnant for bST and control). CONCLUSION: Results failed to indicate a beneficial effect of bST treatment on fertility of lactating dairy cows.

The safety and efficacy of a paclitaxel-eluting wrap for preventing peripheral bypass graft stenosis: a 2-year controlled randomized prospective clinical study.

OBJECTIVES: To compare the safety and efficacy of a bioresorbable paclitaxel-eluting wrap implanted with a synthetic vascular graft (treatment) versus the graft implanted alone (control). DESIGN: Prospective, randomized, controlled, multicentre, 2-year clinical study conducted in adults scheduled to undergo femoropopliteal peripheral bypass surgery with a polytetrafluoroethylene (PTFE) graft. MATERIALS AND METHODS: Hundred and nine subjects were randomized 2:1 to treatment or control. All subjects were implanted with a 6mm expanded PTFE vascular graft; in addition, treated subjects had a 2.5 cm x 4 cm paclitaxel-eluting wrap (1.6 microg/mm(2)) placed around the distal graft anastomosis. RESULTS: The overall incidence of adverse events was similar in both groups. Treated subjects required fewer limb amputations than controls (15.5% vs 18.4%) and time to amputation for those that required amputation was twice as long (153 days vs 76 days). Among diabetics, this effect was pronounced with 13.8% of treated subjects requiring limb amputations compared with 23.5% of controls. Over the course of study, the diameter at the distal graft anastomosis was greater in treated subjects than in controls (difference of 2.1mm at 2 yr, p=0.03). CONCLUSIONS: The paclitaxel-eluting wrap maintained graft patency at the distal anastomosis and was safe to use in patients who had received a peripheral bypass PTFE graft.